Fusion startups are giving the government shares in exchange for awards. Is it worth it?
AI-summarised brief · reviewed before publication
The U.S. Department of Commerce awarded Helion Energy and Commonwealth Fusion Systems a combined $260 million under the CHIPS and Science Act to develop advanced semiconductors for reactor control. Helion received $175 million and CFS $85 million, but both companies must issue non‑voting government shares in exchange. The equity stakes give the federal government roughly a 1 % position in Helion, based on its $15.5 billion Series G valuation; CFS’s share size is undisclosed. These grants mark the most sizable federal infusion into private fusion since the Biden administration’s modest milestone‑based program, which had distributed under $50 million. The awards follow lobbying by the Fusion Industry Association, which has urged a $10 billion infusion to keep the United States competitive with China and other rivals in global race.
💡 Why It Matters
- · The equity component turns taxpayer money into a potential upside, tying public risk to private success and reshaping how the government backs costly clean‑energy breakthroughs.